Development of novel METAP2 inhibitors as potential therapeutics for microsporidiosis

Ended Project Grant Awarded Last action

Award ID
R01AI132614
Recipient
Awarding agency
Obligated
$4,711,566

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $3,920,315.39 Federal
  • $791,251.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$128,063 $0
Amendment $401,250 $0
Amendment $401,250 $0
Amendment $390,001 $0
Amendment $390,001 $0
Amendment $390,001 $390,001
Amendment $401,250 $0
Amendment $401,250 $401,250
Amendment -$226,113 $0
Amendment $226,113 $0
Amendment $414,750 $0
Amendment $0 $0
Amendment $420,625 $0
Amendment $0 $0
Original award $438,000 $0
Show all 15

Quick answers

Who received award R01AI132614?

R01AI132614 was awarded to Long Island University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2018.

How much is award R01AI132614 worth?

$4,711,566 has been obligated on R01AI132614: $3,920,315 in federal funding and $791,251 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award